H. Richard Alexander, MD
University of Maryland School of Medicine
Dr. Richard Alexander is an internationally recognized surgical oncologist and cancer researcher. He treats patients at the University of Maryland Marlene and Stewart Greenebaum Cancer Center and is associate chairman for clinical research in the Department of Surgery of the University of Maryland School of Medicine in Baltimore. Dr. Alexander is recognized for developing innovative techniques to treat patients with regionally advanced cancers of the extremity, peritoneum, or liver. His laboratory is focused on identifying new therapeutic interventions based on elucidating the molecular profiles and cellular pathways that are activated in peritoneal mesothelioma.
Dr. Alexander received his medical degree from the Georgetown University School of Medicine. He completed his residency in general surgery at the National Naval Medical Center in Bethesda and did a fellowship in surgical oncology at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Alexander has written more than 220 journal articles and has lectured throughout the United States and the world.
Claire F. Verschraegen, MD
University of New Mexico
Dr. Claire Verschraegen is currently the Director of Translational Therapeutics at the Cancer Research and Treatment Center of the University of New Mexico. Dr. Verschraegen was on the faculty at M. D. Anderson Cancer Center for seven years before moving to New Mexico. At M. D. Anderson, she became known has a specialist for gynecological cancers, appendiceal cancers, and mesothelioma, studying new anticancer drugs for these diseases. At the University of New Mexico Cancer Research and Treatment Center, she built the Clinical Trial Office and served as the medical director of the New Mexico Cancer Care Alliance, which promotes clinical trials in the community. She is now the Director of the Translational Therapeutics program and continues her clinical research activities in drug development for gynecological cancers and rare malignancies.
John Chabot, MD
Columbia University Medical Center
Dr John Chabot is the Vice Chair for General Surgery and Division Chief, GI/Endocrine Surgery at the NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY. Dr. Chabot is responsible for the surgical management of patients with malignant peritoneal mesothelioma. His current research involves the use of surgery, intraperitoneal chemotherapy and immunotherapy in treating peritoneal mesothelioma.
To view this video, please click on the image below.
